Aukelso Injection
Product Images NDC 83257-030

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Aukelso (NDC 83257-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-01 (Carton 01)

Aukelso (denosumab-kyqq) injection 120 mg/1.7 mL (70 mg/mL) single-dose vial carton by Biocon Biologics Inc. Label indicates subcutaneous injection use only, storage instructions to refrigerate between 2°C to 8°C, and manufacturing at Biocon Biologics Inc., Cambridge, MA, USA. Contains detailed active ingredient and excipient information, barcode, and batch coding area.*

FDA Label Image

Image-01 (Image 01)

A line graph depicting corrected calcium levels over study days in patients treated with Denosumab 120 mg (N = 23). The x-axis represents study days from baseline to day 57, and the y-axes show calcium levels both in mmol/L (left) and mg/dL (right). Data points with error bars illustrate a trend of decreasing calcium levels over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.